• SENSEX 76,295.36
    -322.08 (--0.42%)
  • BANKNIFTY 51,597.35
    249.30 (+0.49%)
  • Mazagon Dock
    2,750.00 2,929.98(%)
  • Tejas Networks
    902.70 1,495.10(%)
  • Hind.Aeronautics
    4,328.95 5,675.00(%)
  • Kalyan Jewellers
    497.15 337.00(%)
  • Adani Power
    538.00 896.75(%)
  • TCS
    3,396.10 3,396.10(%)
  • Reliance Industr
    1,234.55 1,156.00(%)
  • Bharat Electron
    288.30 340.35(%)
  • Persistent Sys
    4,764.75 3,232.60(%)
  • Vodafone Idea
    8.06 6.60(%)
  • Tata Motors
    652.80 606.20(%)
  • Infosys
    1,485.10 1,359.10(%)
  • Angel One
    2,475.00 3,502.60(%)
  • Jio Financial
    231.75 394.70(%)
  • HDFC Bank
    1,776.70 1,430.15(%)
  • Nippon ETF Liq.
    1,000.01 1,005.00(%)
  • Reliance Power
    44.44 54.25(%)
  • Zomato Ltd
    208.35 146.85(%)
  • ICICI Pru. BSE
    999.99 998.75(%)
  • Emcure Pharma
    1,025.75 911.75(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Advanced Enzyme Technologies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 19816.0
  • ISIN : INE837H01020
294.95 10 (3.44%)
  • As on 03 Apr 2025 (EOD)
  • Today’s Low

    281.25
  • Today’s High

    296.00
  • Open

    281.25
  • Perv Close

    285.15
  • 52W Low

    257.90
  • 52W High

    571.00

Key Indicators

  • P/E(TTM)

    31.16

  • Mar.Cap (₹Cr.)

    3,299.93

  • Div & Yield %

    1.73

  • Book Value(₹)

    53.82

  • Debt-Equity Ratio

    3.44

  • AGM Date

    03-Apr-2025

  • EPS

    9.47

  • P/E Ratio

    31.16

Financials Ratios

  • Debt-Equity Ratio

    0.03

  • Mar.Cap (₹Cr.)

    3,299.93

  • RONW (%)

    10.70

  • ROCE (%)

    14.53

Score Board

  • Equity (₹ in Cr.)

    22.38

  • BV (₹)

    53.80

  • Sales( ₹ in Cr.)

    365.47

  • NP (in Cr.)

    123.25

  • NP Var(%)

    120.0

  • Div%

    255.0

  • CPS (₹)

    12.00

  • EPS (₹)

    11.00

  • Traded Value (₹ in Lakhs)

    3,301.05

  • 52 Week High

    571.00

  • 52 Week Low

    257.90

  • Price BSE

    295.0

  • Price NSE

    295.00

  • Market Capital( in Cr.)

    3,301.05

  • P/C Ratio

    24.60

  • P/E Ratio

    26.80

  • Price Vs.BV

    11.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 365.47 311.53 272.80 283.47 247.35 222.09
Excise Duty 365.09 311.28 272.37 282.08 244.92 220.24
Net Sales 365.47 311.53 272.80 283.47 247.35 222.09
Other Income 58.81 9.81 9.08 6.82 9.00 5.61
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 424.28 321.34 281.88 290.30 256.36 227.70
EXPENDITURE :
Raw Materials 365.09 311.28 272.37 282.08 244.92 220.24
Power & Fuel Cost 365.09 311.28 272.37 282.08 244.92 220.24
Employee Cost 49.97 41.42 39.32 34.23 32.61 35.07
Other Manufacturing Expenses 4.23 5.83 3.25 2.95 3.45 3.30
Selling & Administrative Expenses 33.05 32.37 28.66 28.49 25.74 27.93
Miscellaneous Expenses 4.23 5.83 3.25 2.95 3.45 3.30
Less : Pre-operative Expenses Capitalised :
Total Expenditure 271.34 247.06 209.81 191.87 180.50 180.50
Operating Profit 41.30 34.11 29.72 20.78 20.03 17.57
Interest 0.16 0.14 0.10 0.10 1.10 2.23
Gross Profit 133.99 74.28 72.07 98.43 75.85 47.20
Depreciation 10.90 10.28 9.56 9.01 8.81 8.56
Profit Before Tax 133.99 74.28 72.07 98.43 75.85 47.20
Tax 26.95 18.25 18.02 24.84 19.39 11.96
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.08 0.50 -0.46 2.57 -1.49 0.01
Reported Net Profit 108.12 55.53 54.51 71.01 57.96 35.23
Extraordinary Items 133.99 74.28 72.07 98.43 75.85 47.20
Adjusted Net Profit 108.12 55.53 54.51 71.01 57.96 35.23
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 57.03 11.18 11.18 10.06 6.70 6.70
P & L Balance carried down 108.12 55.53 54.51 71.01 57.96 35.23
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 255.00 50.00 50.00 45.00 30.00 30.00
Dividend Per Share(Rs) 5.10 1.00 1.00 0.90 0.60 0.60
Earnings Per Share-Unit Curr 9.67 4.97 4.88 6.36 5.19 3.16
Book Value 57.03 11.18 11.18 10.06 6.70 6.70
Book Value(Adj)-Unit Curr 57.03 11.18 11.18 10.06 6.70 6.70

Shareholding Pattern

  • Promoter Group

    42.93%

  • Public Share Holding

    57.07%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 45,815,885 45,815,885.00 45,815,885 45,815,885
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 45,815,885 40.95 45,815,885 5
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,209,100 1.97 2,209,100 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,209,100 1.97 2,209,100 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 14,069,463 12.58 14,069,463 100
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 6,235,664 5.57 6,235,664 8
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,912,861 2.60 2,912,861 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 23,217,988 20.75 23,217,988 113
2] Non Institution
Bodies Corporate 1,436,378 1.28 1,436,378 380
Clearing Members 1,221 0.00 1,221 6
Directors of their Relatives 1,899,750 1.70 1,899,750 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 3,807,079 3.40 3,807,079 1,723
Foreign Non Institution Other 13,509,522 12.07 13,509,522 1
Hindu Undivided Families 617,938 0.55 617,938 1,488
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,284,293 1.15 1,284,293 5
Individuals holding nominal share capital up to Rs. 1 lakh 16,741,882 14.96 16,528,882 63,606
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 552,701 0.49 552,701 2
Others 763,413 0.68 763,413 13
Sub Total 40,637,677 36.32 40,424,677 67,227
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 111,880,650 100.00 111,667,650 67,351

Company Background

Advanced Enzyme Technologies LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Advanced Enzyme Technologies Ltd
  • BSE Code : 19816.0
  • ISIN : INE837H01020
  • Incorporation Year

    1989

  • Registered Office

    Sun Magnetica 5th Floor
    Nr LIC Serivce Road Louiswadi, Thane,
    Maharashtra-400604

  • Telephone

    91-22-41703200

  • FAX

    91-22-25835159

  • Chairman

    VASANT RATHI

  • Managing Director

  • Company Secretary

    Sanjay Basantani

  • Auditor

    MSKA & Associates

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Advanced Enzyme Technologies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Advanced Enzyme 295.05 424.28 365.47 34.92 27.61
Abbott India 29,940.35 6,097.18 5,848.91 47.68 44.71
Astrazeneca Phar 8,092.00 1,330.33 1,295.53 208.61 33.26
P & G Health Ltd 5,295.80 1,166.89 1,151.26 37.16 39.76
Glaxosmi. Pharma 2,857.90 3,530.73 3,407.25 56.83 44.44
Cipla 1,495.15 17,645.00 16,574.34 25.63 20.10
Amrutanjan Healt 666.30 437.58 421.23 39.06 20.84
Fermenta Biotec. 305.85 315.24 307.09 28.99 4.10
Guj. Themis Bio. 282.25 174.19 169.82 58.44 44.82
Bliss GVS Pharma 126.20 638.96 605.46 28.88 11.19
Ambalal Sarabhai 40.33 11.70 3.81 17.24 1.92